4:01pm ET
Investing
Merck, P&G Lead Dow Stocks Higher Friday
Merck, P&G, IBM, and Exxon Mobil lift DJIA by more than 75 points on Friday.
MRK Coverage Page 38
4:01pm ET
Investing
Exxon Mobil, Merck Weigh on DJIA Thursday
Exxon Mobil, Merck, Goldman Sachs, and Pfizer sink the DJIA on Thursday.
10:15am ET
Health and Healthcare
Merck Is Best Performing DJIA Stock So Far in 2017
Oddly, perhaps, the best performing stock in the first two weeks of the year is drug maker Merck.
Paul Ausick 1:20pm ET
Health and Healthcare
Why 3 Analysts Upgraded Merck Simultaneously
The the attacks against drug pricing and competition do not seem to be going away, but somehow, Merck has managed to find itself as a top pick for pharmaceutical and biohealth analysts.
Jon C. Ogg 10:50am ET
Health and Healthcare
Major Pharma Short Interest Declines Ahead of Trump Comments
The short interest data have been released for the December 30 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through clinical trials.
9:13am ET
Investing
Top Analyst Upgrades and Downgrades: AK Steel, Merck, Twitter, US Steel, Disney, Xerox and More
The the top analyst upgrades, downgrades and initiations on Thursday include AK Steel, Merck, Twitter, U.S. Steel, Walt Disney and Xerox.
4:01pm ET
Investing
Merck, IBM Pace DJIA to Wednesday Gain
Merck, Intel, IBM, Goldman Sachs lead Dow Jones Industrial Average higher Wednesday.
3:22pm ET
Health and Healthcare
Wednesday’s Top Biopharma Movers
Biotech and pharma companies were on the move Wednesday. A few of the smaller caps made tremendous gains on the day, while a couple of the major firms saw massive volume and…
7:45am ET
Investing
Forget 20,000: Why the 2017 DJIA Bull-Bear Outlook Points to 21,422
The DJIA bull-bear projection of 21,422 would be short of the preliminary look of 22,000 seen at the end of December, but another 8.4% gain likely would be more than welcome.
8:50am ET
Investing
Dogs of the Dow Could Be a Huge Winner Again in 2017
There is an investment vehicle that may offer investors a way to stay in equities, get paid solid dividends and have the potential for outperforming total return.
11:05am ET
Health and Healthcare
2017 Bull-Bear Case for Health Care: J&J, Merck, Pfizer, UnitedHealth
Major Dow Jones Industrial Average companies in the health care sector saw a relatively strong 2016, with most posting a solid gain on the year.
8:10am ET
Companies and Brands
How a Slimmer Procter & Gamble Might Fare in 2017
A slimmer portfolio is expected to pay off for Procter & Gamble investors as the company now focuses on 10 product categories where it has about 65 category-leading brands.
4:01pm ET
Investing
Nike, Verizon Lead DJIA Higher Tuesday
ThinkstockJanuary 3, 2017: Markets opened higher Tuesday following the beginning of promised cuts to crude oil production by OPEC members and other nations as well as a strong report on manufacturing activity…
11:14am ET
Investing
Meet the 2017 Dogs of the Dow: Massive Dividends and Expected Upside
One strategy that has been quite common as investors rebalance and make changes each year is the Dogs of the Dow. Meet the 2017 Dogs of the Dow!
4:01pm ET
Investing
Caterpillar, Intel Sink DJIA Wednesday
December 28, 2016: Markets opened higher Wednesday but any recovery from Tuesday’s end-of-day selling failed to materialize. Trading reversed course from Tuesday, where every S&P sector showed a gain, to a trading…